Upper urinary tract carcinoma in lynch syndrome cases

David G. Crockett, David G. Wagner, Sten Holmng, Sonny L. Johansson, Henry T. Lynch

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Purpose Patients with Lynch syndrome are much more likely to have generally rare upper urinary tract urothelial carcinoma but not bladder urothelial carcinoma. While the risk has been quantified, to our knowledge there is no description of how this population of patients with Lynch syndrome and upper urinary tract cancer differs from the general population with upper urinary tract cancer. Materials and Methods We obtained retrospective data on a cohort of patients with Lynch syndrome from the Hereditary Cancer Center in Omaha, Nebraska and compared the data to those on a control general population from western Sweden. These data were supplemented by a new survey about exposure to known risk factors. Results Of the patients with Lynch syndrome 91% had mutations in MSH2 rather than in MSH1 and 79% showed upper tract urothelial carcinoma a mean of 15.85 years after prior Lynch syndrome-type cancer. Median age at diagnosis was 62 years vs 70 in the general population (p <0.0001). Only half of our patients had a significant smoking history and the male-to-female ratio was 0.95. Of patients with Lynch syndrome 51% had urothelial carcinoma in the ureter while it occurred in the renal pelvis in 65% of the general population (p = 0.0013). Similar numbers of high grade tumors were found in the Lynch syndrome and general populations (88% and 74%, respectively, p = 0.1108). Conclusions Upper urinary tract tumors develop at a younger age and are more likely to be in the ureter with an almost equal gender ratio in patients with Lynch syndrome. It has high grade potential similar to that in the general population.

Original languageEnglish (US)
Pages (from-to)1627-1630
Number of pages4
JournalJournal of Urology
Volume185
Issue number5
DOIs
StatePublished - May 1 2011

Fingerprint

Hereditary Nonpolyposis Colorectal Neoplasms
Urinary Tract
Carcinoma
Population
Urologic Neoplasms
Ureter
Neoplasms
Kidney Pelvis
Sweden
Urinary Bladder
Smoking
History
Mutation

Keywords

  • colorectal neoplasms
  • hereditary nonpolyposis
  • ureter
  • urinary tract
  • urologic neoplasms
  • urothelium

ASJC Scopus subject areas

  • Urology

Cite this

Crockett, D. G., Wagner, D. G., Holmng, S., Johansson, S. L., & Lynch, H. T. (2011). Upper urinary tract carcinoma in lynch syndrome cases. Journal of Urology, 185(5), 1627-1630. https://doi.org/10.1016/j.juro.2010.12.102

Upper urinary tract carcinoma in lynch syndrome cases. / Crockett, David G.; Wagner, David G.; Holmng, Sten; Johansson, Sonny L.; Lynch, Henry T.

In: Journal of Urology, Vol. 185, No. 5, 01.05.2011, p. 1627-1630.

Research output: Contribution to journalArticle

Crockett, DG, Wagner, DG, Holmng, S, Johansson, SL & Lynch, HT 2011, 'Upper urinary tract carcinoma in lynch syndrome cases', Journal of Urology, vol. 185, no. 5, pp. 1627-1630. https://doi.org/10.1016/j.juro.2010.12.102
Crockett DG, Wagner DG, Holmng S, Johansson SL, Lynch HT. Upper urinary tract carcinoma in lynch syndrome cases. Journal of Urology. 2011 May 1;185(5):1627-1630. https://doi.org/10.1016/j.juro.2010.12.102
Crockett, David G. ; Wagner, David G. ; Holmng, Sten ; Johansson, Sonny L. ; Lynch, Henry T. / Upper urinary tract carcinoma in lynch syndrome cases. In: Journal of Urology. 2011 ; Vol. 185, No. 5. pp. 1627-1630.
@article{f91eb1b69b264a8c88a9880b86f7002d,
title = "Upper urinary tract carcinoma in lynch syndrome cases",
abstract = "Purpose Patients with Lynch syndrome are much more likely to have generally rare upper urinary tract urothelial carcinoma but not bladder urothelial carcinoma. While the risk has been quantified, to our knowledge there is no description of how this population of patients with Lynch syndrome and upper urinary tract cancer differs from the general population with upper urinary tract cancer. Materials and Methods We obtained retrospective data on a cohort of patients with Lynch syndrome from the Hereditary Cancer Center in Omaha, Nebraska and compared the data to those on a control general population from western Sweden. These data were supplemented by a new survey about exposure to known risk factors. Results Of the patients with Lynch syndrome 91{\%} had mutations in MSH2 rather than in MSH1 and 79{\%} showed upper tract urothelial carcinoma a mean of 15.85 years after prior Lynch syndrome-type cancer. Median age at diagnosis was 62 years vs 70 in the general population (p <0.0001). Only half of our patients had a significant smoking history and the male-to-female ratio was 0.95. Of patients with Lynch syndrome 51{\%} had urothelial carcinoma in the ureter while it occurred in the renal pelvis in 65{\%} of the general population (p = 0.0013). Similar numbers of high grade tumors were found in the Lynch syndrome and general populations (88{\%} and 74{\%}, respectively, p = 0.1108). Conclusions Upper urinary tract tumors develop at a younger age and are more likely to be in the ureter with an almost equal gender ratio in patients with Lynch syndrome. It has high grade potential similar to that in the general population.",
keywords = "colorectal neoplasms, hereditary nonpolyposis, ureter, urinary tract, urologic neoplasms, urothelium",
author = "Crockett, {David G.} and Wagner, {David G.} and Sten Holmng and Johansson, {Sonny L.} and Lynch, {Henry T.}",
year = "2011",
month = "5",
day = "1",
doi = "10.1016/j.juro.2010.12.102",
language = "English (US)",
volume = "185",
pages = "1627--1630",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Upper urinary tract carcinoma in lynch syndrome cases

AU - Crockett, David G.

AU - Wagner, David G.

AU - Holmng, Sten

AU - Johansson, Sonny L.

AU - Lynch, Henry T.

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Purpose Patients with Lynch syndrome are much more likely to have generally rare upper urinary tract urothelial carcinoma but not bladder urothelial carcinoma. While the risk has been quantified, to our knowledge there is no description of how this population of patients with Lynch syndrome and upper urinary tract cancer differs from the general population with upper urinary tract cancer. Materials and Methods We obtained retrospective data on a cohort of patients with Lynch syndrome from the Hereditary Cancer Center in Omaha, Nebraska and compared the data to those on a control general population from western Sweden. These data were supplemented by a new survey about exposure to known risk factors. Results Of the patients with Lynch syndrome 91% had mutations in MSH2 rather than in MSH1 and 79% showed upper tract urothelial carcinoma a mean of 15.85 years after prior Lynch syndrome-type cancer. Median age at diagnosis was 62 years vs 70 in the general population (p <0.0001). Only half of our patients had a significant smoking history and the male-to-female ratio was 0.95. Of patients with Lynch syndrome 51% had urothelial carcinoma in the ureter while it occurred in the renal pelvis in 65% of the general population (p = 0.0013). Similar numbers of high grade tumors were found in the Lynch syndrome and general populations (88% and 74%, respectively, p = 0.1108). Conclusions Upper urinary tract tumors develop at a younger age and are more likely to be in the ureter with an almost equal gender ratio in patients with Lynch syndrome. It has high grade potential similar to that in the general population.

AB - Purpose Patients with Lynch syndrome are much more likely to have generally rare upper urinary tract urothelial carcinoma but not bladder urothelial carcinoma. While the risk has been quantified, to our knowledge there is no description of how this population of patients with Lynch syndrome and upper urinary tract cancer differs from the general population with upper urinary tract cancer. Materials and Methods We obtained retrospective data on a cohort of patients with Lynch syndrome from the Hereditary Cancer Center in Omaha, Nebraska and compared the data to those on a control general population from western Sweden. These data were supplemented by a new survey about exposure to known risk factors. Results Of the patients with Lynch syndrome 91% had mutations in MSH2 rather than in MSH1 and 79% showed upper tract urothelial carcinoma a mean of 15.85 years after prior Lynch syndrome-type cancer. Median age at diagnosis was 62 years vs 70 in the general population (p <0.0001). Only half of our patients had a significant smoking history and the male-to-female ratio was 0.95. Of patients with Lynch syndrome 51% had urothelial carcinoma in the ureter while it occurred in the renal pelvis in 65% of the general population (p = 0.0013). Similar numbers of high grade tumors were found in the Lynch syndrome and general populations (88% and 74%, respectively, p = 0.1108). Conclusions Upper urinary tract tumors develop at a younger age and are more likely to be in the ureter with an almost equal gender ratio in patients with Lynch syndrome. It has high grade potential similar to that in the general population.

KW - colorectal neoplasms

KW - hereditary nonpolyposis

KW - ureter

KW - urinary tract

KW - urologic neoplasms

KW - urothelium

UR - http://www.scopus.com/inward/record.url?scp=79953772082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953772082&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2010.12.102

DO - 10.1016/j.juro.2010.12.102

M3 - Article

C2 - 21419447

AN - SCOPUS:79953772082

VL - 185

SP - 1627

EP - 1630

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 5

ER -